Clinical Applications of Molecular Biomarkers in Prostate Cancer

Clinical Applications of Molecular Biomarkers in Prostate Cancer

There is clinically relevant molecular heterogeneity in prostate cancer (PCa), but this biological diversity has had only a minimal impact on clinical practice. Treatment outcomes in patients with localised PCa are often highly variable, even among patients stratified to the same risk group or disea...

Full description

Bibliographic Details
Main Authors: Felipe Couñago, Fernando López-Campos, Ana Aurora Díaz-Gavela, Elena Almagro, Esaú Fenández-Pascual, Iván Henríquez, Rebeca Lozano, Estefanía Linares Espinós, Alfonso Gómez-Iturriaga, Guillermo de Velasco, Luis Miguel Quintana Franco, Ignacio Rodríguez-Melcón, José López-Torrecilla, Daniel E. Spratt, Luis Leonardo Guerrero, Juan Ignacio Martínez-Salamanca, Elia del Cerro
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
biomarkers
DNA repair
gene panels
genetic testing
germline mutation
precision medicine
Online Access:https://www.mdpi.com/2072-6694/12/6/1550

Internet

https://www.mdpi.com/2072-6694/12/6/1550

Similar Items